First Heartland Consultants’s GSK GSK Stock Holding History

First Heartland Consultants’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,844	Closed	-$532K	–	552
2025 Q4	$532K	Buy	10,844 +17	+0.2%	+$793	0.04%	282
2025 Q3	$467K	Sell	10,827 -4	-0%	-$156	0.04%	301
2025 Q2	$416K	Buy	10,831 +1,767	+19%	+$67.5K	0.04%	311
2025 Q1	$351K	Buy	+9,064	New	+$332K	0.04%	311

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

First Heartland Consultants's GSK Position: Q1 2026 in Review

First Heartland Consultants sold out of GSK (GSK) in Q1 2026, closing a stake of 10,844 shares — an estimated $532K sold.

First Heartland Consultants first reported a position in GSK in Q1 2025 and held it in 4 quarters. The position peaked at $532K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

First Heartland Consultants reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
First Heartland Consultants sold 10,844 GSK shares in Q1 2026, an estimated $532K.
First Heartland Consultants first reported a position in GSK in Q1 2025 and held it in 4 quarters.
First Heartland Consultants's GSK position peaked at $532K in Q4 2025.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on First Heartland Consultants's 13F filing for Q1 2026, filed 8 Apr 2026.